Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Sch-217048: potent and selective neurokinin antagonist from natural sources

Feb. 8, 1999

Genelabs Technologies' DARPA drug discovery grant renewed

Feb. 8, 1999

AxyS and Protein Design Labs enter drug discovery agreement

Feb. 2, 1999

BioFocus and Pharmacia & Upjohn join forces in drug discovery

Feb. 1, 1999

Abgenix and Genentech form new antibody collaboration

Jan. 29, 1999

Deltagen and Pfizer establish target validation agreement

Jan. 29, 1999

Three patents covering drug formulation technology issued to Delsys

Jan. 28, 1999

Deltagen enters another gene target validation collaboration

Jan. 28, 1999

Deltagen to validate target genes for Roche Bioscience

Jan. 26, 1999

Results of animal studies indicate ability of GeneSwitch to regulate gene therapy

Jan. 22, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Latus Bio series A financing supports early-stage programs
BioWorld Science
Latus Bio Inc. has closed a $97 million series A financing to support its broad therapeutics pipeline based on novel AAV capsid variants. Proceeds from the...